ल्यूपिन शेयर मूल्य लक्ष्य 2025, 2030, 2040, 2050
Lupin is one of the largest Indian pharmaceutical companies which makes and sells a variety of medicines at very affordable prices. The company is well known for its medicine for diabetes, heart problems, lung conditions, and mental health.
The company do business in the country and it supplies its product to the outside of the country.
- 1 What is Lupin Ltd NSE: LUPIN?
- 2 Lupin Share Price Target Tomorrow
- 3 Lupin Share Price Target 2025
- 4 शेयर मूल्य लक्ष्य 2030
- 5 शेयर मूल्य लक्ष्य 2040
- 6 शेयर मूल्य लक्ष्य 2050
- 7 Should I Buy Lupin Stock?
- 8 Lupin Ltd Earning Results
- 9 Is Lupin Stock Good to Buy? (Bull case & Bear case)
- 10 निष्कर्ष
- 11 पूछे जाने वाले प्रश्न
What is Lupin Ltd NSE: LUPIN?
Lupin Limited is an Indian company that makes a wide range of medicines including, biosimilars, generic drugs, and over-the-counter (OTC) medicines in over 100 countries like the U.S., India, South Africa, Asia, Latin America, Europe, and the Middle East. The company is well-known for its medicines for diabetes, heart problems, and breathing issues, as well as treatments for infections, stomach problems, and brain health. It was established in 1968 by Desh Bandhu Gupta.
The stock is currently in an uptrend but this rise seems to be getting weaker. The price is below the important level of 2216 on the chart. If it stays below this level, the stock might fall in the short term. For tomorrow, the stock may be moved sideways as there is no big trade by the company. It’s a good idea to wait and see how it performs in the first half of the day. If it shows weakness later in the day, this trend might continue. If it shows strength, the trend could continue in the next trading session.
The price would be between ₹2198 to ₹2275 in 2024.
| दिवस | Minimum target (Rs) | Maximum target (Rs) |
| Tomorrow | -28 | +35 |
आगे के वर्षों की तलाश में, इसका मूल बहुत अच्छा है। लूपिन की मार्केट कैप मजबूत दिख रही है। कंपनी के पास बहुत कम ऋण है, जिसमें 0.20 का डेट-टू- इक्विटी अनुपात है, जिसका अर्थ है कि इसमें बहुत कम ऋण है और भविष्य में अच्छा रिटर्न दे सकता है। हाल के वर्षों में, शेयर ने बहुत अच्छी तरह से प्रदर्शन किया है। विशेषज्ञों का मानना है कि 2025 में, इसका शेयर मूल्य लक्ष्य होगा ₹2500।
2025 में, इसकी शेयर कीमत के बीच होगी ₹1786 to ₹2500।
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2025 | 1786 | 2500 |
| महीना | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| जनवरी | 1998 | 2402 |
| फ़रवरी | 1860 | 2225 |
| मार्च | 1873 | 2180 |
| अप्रैल | 1800 | 2211 |
| मई | 1786 | 2250 |
| जून | 1887 | 2278 |
| जुलाई | 1935 | 2290 |
| अगस्त | 1954 | 2322 |
| सितंबर | 1988 | 2354 |
| अक्टूबर | 2045 | 2374 |
| नवंबर | 2212 | 2443 |
| दिसम्बर | 2354 | 2500 |
This company has grown fast in India because it makes good medicines that people need. It also provides many heart medicines, which has helped it expand to over 70 countries. As it is a very old company, people trust this company’s products. It has a very strong brand value in the market. Its stock price faced many ups and downs but ultimately for the long-term investors it gave a good profit. It is one of the top companies in the medical sector. For the year 2030, its share price target would be ₹6400.
By 2030, its share price would be between ₹5500 to ₹6400.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2030 | 5500 | 6400 |
| महीना | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| जनवरी | 5500 | 5631 |
| फ़रवरी | 5567 | 5670 |
| मार्च | 5600 | 5700 |
| अप्रैल | 5550 | 5760 |
| मई | 5640 | 5800 |
| जून | 5700 | 5930 |
| जुलाई | 5840 | 5900 |
| अगस्त | 5890 | 6100 |
| सितंबर | 5940 | 6173 |
| अक्टूबर | 6000 | 6250 |
| नवंबर | 6123 | 6300 |
| दिसम्बर | 6280 | 6400 |
As India’s population grows, people are getting sick more often and need more medicine. To meet this demand, the company is expanding its production and opening new branches. The company makes over 180 medicines and is the third-largest drug company in India. On the other hand, The company has given a more than 100% return over the last 5 years. The company could offer very good returns in the future. If the company keeps growing and managing well, it could give very good returns. In 2040, its share price target would be ₹8900.
By 2040, its share price would be between ₹8100 to ₹8900.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2040 | 8100 | 8900 |
| महीना | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| जनवरी | 8100 | 8230 |
| फ़रवरी | 8185 | 8280 |
| मार्च | 8200 | 8346 |
| अप्रैल | 8267 | 8350 |
| मई | 8290 | 8400 |
| जून | 8330 | 8450 |
| जुलाई | 8300 | 8570 |
| अगस्त | 8450 | 8683 |
| सितंबर | 8546 | 8712 |
| अक्टूबर | 8621 | 8767 |
| नवंबर | 8715 | 8780 |
| दिसम्बर | 8825 | 8900 |
The company is known for its quality and genuine pricing. It’s not only known in India but in the foreign country, and its medicine is in high demand. It made medicine for major diseases like heart attacks, mental health, diabetes and so on. At the current time, it is one of the biggest brands in the medical line. The company gained much trust from the people. So in the coming year, its share price will be seen to be on an uptrend. In 2050, its stock price target would be ₹14000.
In 2050, its share price could be between ₹12200 to ₹14000.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2050 | 12200 | 14000 |
| महीना | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| जनवरी | 12200 | 12357 |
| फ़रवरी | 12270 | 12442 |
| मार्च | 12340 | 12530 |
| अप्रैल | 12400 | 12631 |
| मई | 12540 | 12738 |
| जून | 12609 | 12900 |
| जुलाई | 12690 | 13030 |
| अगस्त | 12875 | 13100 |
| सितंबर | 13056 | 13360 |
| अक्टूबर | 13400 | 13625 |
| नवंबर | 13600 | 13831 |
| दिसम्बर | 13780 | 14000 |
मैं खरीदना चाहिए Lupin शेयर?
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2025 | 1786 | 2500 |
| 2030 | 5500 | 6400 |
| 2040 | 8100 | 8900 |
| 2050 | 12200 | 14000 |
The company’s best-selling medicines include drugs for diabetes, infections, heart problems, and asthma. This company also makes and sells brand-name drugs like Lupitac, Metoject, and Lupizole. If you want to invest in a pharma company or are thinking about it, Lupin stock could be a good option for you. In the past year, Lupin stock has gone up by over 100%, making investors very happy.
Lupin Ltd Earning Results
| Mcap Full (Cr.) | 1,02,441.62 |
| टर्नओवर (सीआर) | 19.43 |
| टीटीक्यू (लख) | 0.86 |
| ईपीएस (टीटीएम) | 60.06 |
| सीईपीएस (टीटीएम) | 75.99 |
| PE/PB | 36.78 / 4.89 |
| ROE | 13.29 |
| फेस वैल्यू | 2.00 |
| एनपीएम % | 21.34 |
| OPM % | 29.70 |
| कैश ईपीएस | 22.60 |
| ईपीएस | 19.51 |
| राजस्व | 4,167.63 |
| नेट लाभ | 889.18 |
क्या है Lupin स्टॉक खरीदना अच्छा है? (Bull case & Bear case)
Bull Case :
- it is growing well, with new medicines and expanding in global markets.
- It has shown better sales and profits recently, giving strong returns to investors.
- There is increasing demand for medicines worldwide, especially for cheaper, generic drugs, which Lupin makes a lot of.
Bear Case :
- It faces strict rules in different countries. If they fail to meet these rules, they could face fines or bans.
- There are many other companies making similar medicines.
निष्कर्ष
In this article, we give you all the important information about Lupin. If you are planning to invest in its share or have already invested, this article can be very helpful. We discussed everything from the basics of the company to its future plans and analysis. we have given you the multiple time frame price prediction so please read the whole article to know in depth.
